191 related articles for article (PubMed ID: 8335485)
1. [p53--a gene for suppression of tumors?].
Wustrow TD
HNO; 1993 May; 41(5):A12-3. PubMed ID: 8335485
[No Abstract] [Full Text] [Related]
2. [Significance of aberrant p53 protein in head-neck tumors and its effect on proliferation and differentiation].
Homann N; Andl T; Nees M; Schuhmann A; Herold-Mende C; Bosch FX
HNO; 1993 May; 41(5):254-60. PubMed ID: 8392993
[TBL] [Abstract][Full Text] [Related]
3. [Cell protein p53 in head-neck tumors].
Issing WJ
HNO; 1994 May; 42(5):249-50. PubMed ID: 8050909
[No Abstract] [Full Text] [Related]
4. [Cell cycle and cancer].
Dietrich C
Med Monatsschr Pharm; 1998 Mar; 21(3):69-75. PubMed ID: 9556975
[No Abstract] [Full Text] [Related]
5. Molecular biology of brain tumors.
Wu JK; Naber SP
Neurosurg Clin N Am; 1994 Jan; 5(1):127-33. PubMed ID: 8124087
[TBL] [Abstract][Full Text] [Related]
6. Molecular biology of head and neck tumorigenesis: the role of p53 expression and genetic instability.
Charuruks N; Voravud N
J Med Assoc Thai; 1996 Dec; 79 Suppl 1():S3-10. PubMed ID: 9071061
[TBL] [Abstract][Full Text] [Related]
7. [Genetic principles of malignant transformation].
Maly K
Acta Med Austriaca; 1992; 19(4):91-5. PubMed ID: 1290321
[TBL] [Abstract][Full Text] [Related]
8. [Oncogenes and tumor suppressor genes: genetic changes mark the adenoma-carcinoma sequence].
Schmiegel WH
Internist (Berl); 1991 Jun; 32(6):315-20. PubMed ID: 1652573
[No Abstract] [Full Text] [Related]
9. P53 expression and polysomies of chromosome 9, 17 in head and neck cancer prognosis.
Charuruks N; Shin DM; Voravud N; Ro JY; Hong WK; Hittelman WN
J Med Assoc Thai; 1999 May; 82(5):466-76. PubMed ID: 10443096
[TBL] [Abstract][Full Text] [Related]
10. Genetic instabilities of chromosome 9, 17 and accumulation of p53 overexpression during multistage tumorigesis in head and neck cancer.
Charuruks N; Shin DM; Voravud N; Ro JY; Hong WK; Hittelman WN
J Med Assoc Thai; 1996 Dec; 79 Suppl 1():S104-12. PubMed ID: 9071074
[TBL] [Abstract][Full Text] [Related]
11. Analysis of oncogene, tumor suppressor gene, and chromosomal alterations in HeLa x osteosarcoma somatic cell hybrids.
Isfort RJ; Cody DB; Lovell GJ; Gioeli D; Weissman BE; Doersen CJ
Mol Carcinog; 1999 May; 25(1):30-41. PubMed ID: 10331742
[TBL] [Abstract][Full Text] [Related]
12. [Molecular genetic changes in hypophyseal adenomas].
Mennel HD
Strahlenther Onkol; 2001 Jul; 177(7):373-4. PubMed ID: 11505626
[No Abstract] [Full Text] [Related]
13. Genetic alterations associated with bladder cancer.
Cordon-Cardo C; Dalbagni G; Sarkis AS; Reuter VE
Important Adv Oncol; 1994; ():71-83. PubMed ID: 7911446
[No Abstract] [Full Text] [Related]
14. [Cancer and the cell cycle: a current merry-go-round in oncology of clinical relevance].
Fey MF
Schweiz Med Wochenschr; 1998 Apr; 128(16):629-37. PubMed ID: 9611306
[TBL] [Abstract][Full Text] [Related]
15. Effects of p53 or p27 overexpression on cyclooxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines.
Lee DW; Park SW; Park SY; Heo DS; Kim KH; Sung MW
Head Neck; 2004 Aug; 26(8):706-15. PubMed ID: 15287038
[TBL] [Abstract][Full Text] [Related]
16. Tumour suppressor genes: nature's defence against cancer.
Robinson A
CMAJ; 1993 Aug; 149(3):310-3. PubMed ID: 8339177
[No Abstract] [Full Text] [Related]
17. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
Crowe DL; Sinha UK
Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195
[TBL] [Abstract][Full Text] [Related]
18. Tumor suppressor genes in the 9p21 gene cluster are selective targets of inactivation in neuroendocrine gastroenteropancreatic tumors.
Lubomierski N; Kersting M; Bert T; Muench K; Wulbrand U; Schuermann M; Bartsch D; Simon B
Cancer Res; 2001 Aug; 61(15):5905-10. PubMed ID: 11479232
[TBL] [Abstract][Full Text] [Related]
19. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
Andrews GA; Xi S; Pomerantz RG; Lin CJ; Gooding WE; Wentzel AL; Wu L; Sidransky D; Grandis JR
Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206
[TBL] [Abstract][Full Text] [Related]
20. [Clinical significance of tumor suppressor gene p53 in head and neck tumors].
Preisler V; Kirchner S; Hagen R
HNO; 1997 Sep; 45(9):659-62. PubMed ID: 9417443
[No Abstract] [Full Text] [Related]
[Next] [New Search]